Ten Capital Wealth Advisors’s iShares Biotechnology ETF IBB Stock Holding History

Ten Capital Wealth Advisors’s Portfolio IBB Stock Details IBB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	–	Sell	-56	Closed	-$7.23K	–	336
2023 Q1	$7.23K	Buy	+56	New	+$7.33K	﹤0.01%	393
2022 Q2	–	Sell	-117	Closed	-$15K	–	489
2022 Q1	$15K	Buy	+117	New	+$15.2K	0.01%	245

Other funds holding IBB

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Citigroup New York $235B AUM 32.99% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

BNP Paribas Financial Markets Paris, France $206B AUM 31.61% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Commerce Bank Kansas City, Missouri $20.7B AUM 23.76% 1-Year Est. Return

Healthcare of Ontario Pension Plan (HOOPP) Trust Fund Toronto, Ontario, Canada $62.2B AUM 31.35% 1-Year Est. Return

Ten Capital Wealth Advisors's IBB Position: Q2 2023 in Review

Ten Capital Wealth Advisors sold out of iShares Biotechnology ETF (IBB) in Q2 2023, closing a stake of 56 shares — an estimated $7.23K sold.

Ten Capital Wealth Advisors first reported a position in IBB in Q1 2022 and held it in 2 quarters. The position peaked at $15K in Q1 2022. 844 funds tracked by Wall St. Rank hold IBB as of Q2 2023.

Ten Capital Wealth Advisors reported no remaining iShares Biotechnology ETF position as of Q2 2023 after selling out during the quarter.
Ten Capital Wealth Advisors sold 56 iShares Biotechnology ETF shares in Q2 2023, an estimated $7.23K.
Ten Capital Wealth Advisors first reported a position in iShares Biotechnology ETF in Q1 2022 and held it in 2 quarters.
Ten Capital Wealth Advisors's iShares Biotechnology ETF position peaked at $15K in Q1 2022.
844 funds tracked by Wall St. Rank held iShares Biotechnology ETF as of Q2 2023.

Based on Ten Capital Wealth Advisors's 13F filing for Q2 2023, filed 31 Jul 2023.